Literature DB >> 7853210

Are postsynaptic 5-HT1A receptors involved in the anxiolytic effects of 5-HT1A receptor agonists and in their inhibitory effects on the firing of serotonergic neurons in the rat?

T Jolas1, R Schreiber, A M Laporte, M Chastanet, J De Vry, T Glaser, J Adrien, M Hamon.   

Abstract

Previous studies have shown that injection of 5-hydroxytryptamine (serotonin) receptor agonists in the dorsal raphe nucleus (DRN) to stimulate somatodendritic 5-HT1A autoreceptors or in the hippocampus to stimulate postsynaptic 5-HT1A receptors, induces anxiolytic-like effects in the rat. The mechanisms triggered by the latter treatment were investigated by measuring both the electrical activity of serotonergic DRN neurons and the anxiolytic response in rats receiving injections with 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) or ipsapirone into the dorsal hippocampus. Anxiety-related behavior was estimated by recording the time of ultrasonic vocalization (USV) due to electric foot shocks under standardized conditions. Intrahippocampal application of 8-OH-DPAT or ipsapirone produced a dose-dependent inhibition of the firing of serotonergic DRN neurons and of the shock-induced USV response. However, the range of efficient doses of 8-OH-DPAT via the intrahippocampal route (1-10 micrograms/rat) was larger than that using the i.v. route of injection (0.15-2.5 micrograms/rat). Furthermore, maximal inhibition of the firing of DRN serotonergic neurons occurred earlier when 8-OH-DPAT was injected i.v. (within 1-2 min) than when it was injected into the dorsal hippocampus (within 5 min). Interestingly, the injection of 8-OH-DPAT into the striatum, where 5-HT1A receptors are hardly detectable, or a lateral ventricle, also yielded dose-dependent reduction in both the firing rate of serotonergic DRN neurons and the USV response. Finally, local lesion with ibotenic acid to eliminate postsynaptic 5-HT1A receptors did not alter the inhibitory effects of intrahippocampal application of 8-OH-DPAT on the firing of serotonergic DRN neurons and the USV response. These data indicated that postsynaptic 5-HT1A receptors were not responsible for the inhibitory effects of 8-OH-DPAT and ipsapirone injected in forebrain areas on the electrical activity of serotonergic neurons and the USV response in rats. As shown by the autoradiographic labeling by [3H]8-OH-DPAT at distance from its injection site in the dorsal hippocampus, the diffusion of 5-HT1A receptor agonists (from injected areas in the forebrain to the DRN where they directly inhibit the electrical activity of serotonergic neurons) more likely accounted for their anxiolytic-like effects.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7853210

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  20 in total

1.  Role of the medial prefrontal cortex in 5-HT1A receptor-induced inhibition of 5-HT neuronal activity in the rat.

Authors:  M Hajós; E Hajós-Korcsok; T Sharp
Journal:  Br J Pharmacol       Date:  1999-04       Impact factor: 8.739

2.  Cellular correlates of anxiety in CA1 hippocampal pyramidal cells of 5-HT1A receptor knockout mice.

Authors:  Emily Freeman-Daniels; Sheryl G Beck; Lynn G Kirby
Journal:  Psychopharmacology (Berl)       Date:  2010-10-28       Impact factor: 4.530

3.  In vivo quantification of human serotonin 1A receptor using 11C-CUMI-101, an agonist PET radiotracer.

Authors:  Matthew S Milak; Christine DeLorenzo; Francesca Zanderigo; Jaya Prabhakaran; J S Dileep Kumar; Vattoly J Majo; J John Mann; Ramin V Parsey
Journal:  J Nucl Med       Date:  2010-12       Impact factor: 10.057

Review 4.  5-HT(1A) receptor function in major depressive disorder.

Authors:  Jonathan Savitz; Irwin Lucki; Wayne C Drevets
Journal:  Prog Neurobiol       Date:  2009-02-07       Impact factor: 11.685

5.  Increased anxiety of mice lacking the serotonin1A receptor.

Authors:  C L Parks; P S Robinson; E Sibille; T Shenk; M Toth
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

6.  Somatodendritic 5-HT1A receptors are critically involved in the anxiolytic effects of 8-OH-DPAT.

Authors:  S M Remy; R Schreiber; M Dalmus; J De Vry
Journal:  Psychopharmacology (Berl)       Date:  1996-05       Impact factor: 4.530

7.  A five minute experience in the elevated plus-maze alters the state of the benzodiazepine receptor in the dorsal raphe nucleus.

Authors:  L E Gonzalez; S E File
Journal:  J Neurosci       Date:  1997-02-15       Impact factor: 6.167

8.  Neurochemical and behavioural effects of hypidone hydrochloride (YL-0919): a novel combined selective 5-HT reuptake inhibitor and partial 5-HT1A agonist.

Authors:  Li-Ming Zhang; Xiao-Yun Wang; Nan Zhao; Yu-Lu Wang; Xiao-Xu Hu; Yu-Hua Ran; Yan-Qin Liu; You-Zhi Zhang; Ri-Fang Yang; Yun-Feng Li
Journal:  Br J Pharmacol       Date:  2017-03-21       Impact factor: 8.739

9.  Modeling considerations for 11C-CUMI-101, an agonist radiotracer for imaging serotonin 1A receptor in vivo with PET.

Authors:  Matthew S Milak; Alin J Severance; R Todd Ogden; Jaya Prabhakaran; J S Dileep Kumar; Vattoly J Majo; J John Mann; Ramin V Parsey
Journal:  J Nucl Med       Date:  2008-03-14       Impact factor: 10.057

10.  Dihydroergotamine and its metabolite, 8'-hydroxy-dihydroergotamine, as 5-HT1A receptor agonists in the rat brain.

Authors:  N Hanoun; F Saurini; L Lanfumey; M Hamon; S Bourgoin
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.